These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 33178530)
21. Euglycemic Diabetic Ketoacidosis Precipitated by SGLT-2 Inhibitor Use, Pericarditis, and Fasting: A Case Report. Mendelsohn RA; Taveras AN; Mazer BA; Clayton LM Clin Pract Cases Emerg Med; 2020 Aug; 4(3):389-392. PubMed ID: 32926693 [TBL] [Abstract][Full Text] [Related]
22. Canagliflozin-Induced Diabetic Ketoacidosis: Case Report and Review of the Literature. Turner J; Begum T; Smalligan RD J Investig Med High Impact Case Rep; 2016; 4(3):2324709616663231. PubMed ID: 27635409 [TBL] [Abstract][Full Text] [Related]
23. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. Andrews TJ; Cox RD; Parker C; Kolb J J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592 [TBL] [Abstract][Full Text] [Related]
24. A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery. Osafehinti DA; Okoli OJ; Karam JG AACE Clin Case Rep; 2021; 7(1):20-22. PubMed ID: 33851014 [TBL] [Abstract][Full Text] [Related]
25. Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice. Patoulias D; Manafis A; Mitas C; Avranas K; Lales G; Zografou I; Sambanis C; Karagiannis A Cardiovasc Hematol Disord Drug Targets; 2018; 18(2):139-146. PubMed ID: 29412120 [TBL] [Abstract][Full Text] [Related]
26. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature. Burke KR; Schumacher CA; Harpe SE Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088 [TBL] [Abstract][Full Text] [Related]
29. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors. Vitale RJ; Valtis YK; McDonnell ME; Palermo NE; Fisher NDL AACE Clin Case Rep; 2021; 7(1):10-13. PubMed ID: 33521255 [TBL] [Abstract][Full Text] [Related]
30. Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature. Mistry S; Eschler DC AACE Clin Case Rep; 2021; 7(1):17-19. PubMed ID: 33851013 [TBL] [Abstract][Full Text] [Related]
31. Sodium-glucose cotransporter-2 inhibitors induced euglycemic diabetic ketoacidosis: Two case reports and a review of the literature. Bitar ZI; Maadarani OS; Alabdali F; Teama A; Elsawah W; Mohsen MJ; Elzoueiry MM Clin Case Rep; 2022 Feb; 10(2):e05440. PubMed ID: 35169474 [TBL] [Abstract][Full Text] [Related]
32. Euglycemic Diabetic Ketoacidosis Due to SGLT2 Inhibitor in a Patient With Gitelman Syndrome: A Therapeutic Dilemma. Ahmed T; Karimi H; Hegde V; Lodhi SH Cureus; 2021 Oct; 13(10):e19169. PubMed ID: 34873512 [TBL] [Abstract][Full Text] [Related]
33. Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers. Somagutta MR; Agadi K; Hange N; Jain MS; Batti E; Emuze BO; Amos-Arowoshegbe EO; Popescu S; Hanan S; Kumar VR; Pormento K Cureus; 2021 Mar; 13(3):e13665. PubMed ID: 33824816 [TBL] [Abstract][Full Text] [Related]
34. Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin. Kelmenson DA; Burr K; Azhar Y; Reynolds P; Baker CA; Rasouli N J Investig Med High Impact Case Rep; 2017; 5(2):2324709617712736. PubMed ID: 28634592 [TBL] [Abstract][Full Text] [Related]
35. Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter 2 Inhibitor Use in Two Patients Undergoing Pancreatectomy. Pace DJ; Dukleska K; Phillips S; Gleason V; Yeo CJ J Pancreat Cancer; 2018; 4(1):95-99. PubMed ID: 30631862 [No Abstract] [Full Text] [Related]
36. EUGLYCEMIC DIABETIC KETOACIDOSIS AND SEVERE ACUTE KIDNEY INJURY SECONDARY TO OFF LABEL USE OF SODIUM GLUCOSE COTRANSPORTER-2 INHIBITOR IN A TYPE-1 DIABETIC PATIENT. Tahir H; Wani A; Daruwalla V; Daboul N; Sagi J J Ayub Med Coll Abbottabad; 2015; 27(4):923-4. PubMed ID: 27004352 [TBL] [Abstract][Full Text] [Related]
37. Life-Threatening Complications Related to Delayed Diagnosis of Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Report of 2 Cases. Goto S; Ishikawa JY; Idei M; Iwabuchi M; Namekawa M; Nomura T Am J Case Rep; 2021 Mar; 22():e929773. PubMed ID: 33723205 [TBL] [Abstract][Full Text] [Related]
38. A Case of Euglycemic Diabetic Ketoacidosis (DKA), Influenza, and a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor. Jeong SH; Vorachitti M; Fuentes F Cureus; 2023 May; 15(5):e39012. PubMed ID: 37378199 [TBL] [Abstract][Full Text] [Related]
39. Sodium-Glucose Co-transporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Bariatric Surgery: A Case and Literature Review. Kapila V; Topf J Cureus; 2021 Aug; 13(8):e17093. PubMed ID: 34527480 [TBL] [Abstract][Full Text] [Related]